Search

PerkinElmer Inc

Lezárt

SzektorEgészségügy

0

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

Maximum

Fő mutatók

By Trading Economics

Bevétel

13M

53M

Értékesítés

19M

730M

P/E

Szektor átlag

74.455

48.735

Egy részvényre jutó nyereség

1.41

Osztalékhozam

0.18

Profit margin

7.329

Munkavállalók

11,000

EBITDA

8.8M

189M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

-10.8% downside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

0.18%

2.24%

Következő eredményjelentés

2026. nov. 3.

Következő osztalékfizetési dátum

2026. nov. 13.

Következő korábbi osztalék dátum

2026. okt. 23.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

4.5B

17B

Előző nyitás

0

Előző zárás

0

PerkinElmer Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. okt. 16. 21:02 UTC

Revvity Inc's shares are declining in after-market trading, hitting their lowest level since Friday's close amid ongoing price weakness.

2026. okt. 15. 23:46 UTC

Revvity Inc's shares declined modestly in after-market trading, following earlier gains, and remain near the upper end of their one-month range.

2026. okt. 14. 23:46 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a decline that began after Wednesday's close.

2026. okt. 13. 20:13 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a downward trend since Tuesday's close amid unusual weakness during the session.

2026. okt. 12. 19:51 UTC

Revvity Inc shares are advancing, continuing a higher trend since Friday's close, despite currently trading lower in today's session.

2026. okt. 8. 20:06 UTC

Revvity Inc shares are declining, having pulled back from earlier gains amid a broader market trend lower since Wednesday's close.

2026. okt. 7. 19:25 UTC

News

Barclays raised Revvity Inc's price target to $160.00 from $115.00, maintaining an Equal-weight rating, as the stock trades modestly higher.

2026. okt. 6. 22:41 UTC

News

Revvity Inc shares declined in after-market trading despite an Outperform rating from William Blair, closing at their lowest point since Tuesday.

2026. okt. 5. 19:21 UTC

Correlated Moves

Revvity Inc is advancing, likely influenced by a significant rise in shares of Charles River Laboratories, reaching its best cumulative return since Friday's close.

2026. okt. 2. 19:45 UTC

News

Revvity Inc. will release Q3 2026 financial results on November 3, 2026, contributing to the stock's upward movement today, despite a slight retracement.

2026. okt. 1. 20:03 UTC

Revvity Inc shares fell sharply from an early peak, currently trading near their lowest point of the day despite being above the 20-day moving average.

2026. szept. 30. 21:02 UTC

Revvity Inc is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month range.

2026. szept. 29. 19:36 UTC

Revvity Inc is trading higher, reaching a peak return since Monday's close and maintaining a position above its 20-day moving average.

2026. szept. 28. 20:20 UTC

Revvity Inc's shares are trading modestly lower in after-market hours, shifting from a slight gain to a loss since Monday's close.

2026. szept. 25. 20:01 UTC

Revvity Inc shares fell sharply, pulling back from earlier gains and currently trading below Thursday's close despite being above its 20-day moving average.

2026. szept. 24. 23:11 UTC

Revvity Inc has advanced modestly in after-market trading, remaining significantly above its 20-day moving average and showing notable gains over the past month.

2026. szept. 23. 20:07 UTC

Revvity Inc shares fell sharply, settling below Tuesday's close after an early peak, though remaining above the 20-day moving average.

2026. szept. 22. 19:31 UTC

Revvity Inc shares fell sharply after briefly gaining earlier, but remain above their 20-day moving average and near the upper end of their one-month range.

2026. szept. 21. 23:56 UTC

Revvity Inc is trading modestly higher in after-market hours, positioned above its 20-day moving average and near the upper end of its one-month range.

2026. szept. 16. 20:07 UTC

Revvity Inc is trading higher, continuing a strong momentum with four consecutive sessions of gains and remaining well above its 20-day moving average.

2026. szept. 15. 22:02 UTC

Revvity Inc. shares are lower in after-market trading, reflecting broader market trends amid economic concerns following a significant drop in the NY Empire State Manufacturing Index.

2026. szept. 14. 20:08 UTC

Revvity Inc shares are higher in Monday's session, continuing a broader upward trend since Friday. The stock is above its 20-day moving average.

2026. szept. 11. 20:08 UTC

News

Revvity Inc will acquire Human Cell Design to enhance its Life Sciences sector reach. Shares are rising today after five consecutive lower sessions.

2026. szept. 9. 20:07 UTC

News
Event

Revvity Inc announced its acquisition of Human Cell Design to enhance its Life Sciences portfolio. Shares are trading lower amid broader market weakness.

2026. szept. 8. 20:07 UTC

Revvity Inc shares are lower today, continuing a decline since Friday's close. The stock opened down and remained weak throughout the session.

2026. szept. 4. 19:47 UTC

News

Revvity Inc shares are lower amid mixed analyst ratings and price target adjustments. Earlier, shares pulled back from a session high during ongoing market volatility.

2026. szept. 3. 20:07 UTC

News

Revvity Inc shares are lower today, reaching a low of -2.18%. Analyst Catherine Ramsey Schulte raised the price target to $144.00 from $131.00.

2026. szept. 2. 21:02 UTC

Revvity Inc shares are higher in after-market trading, with no specific news identified. The broader market context includes a disappointing ADP employment report.

2026. szept. 1. 19:43 UTC

News

Revvity shares are lower as RBC Capital initiates coverage with a Sector Perform rating and a price target of $135.

2026. aug. 31. 20:07 UTC

Revvity Inc shares are lower amid broader market reactions to inflation comments from Warsh at the Jackson Hole Economic Symposium.

Társak összehasonlítása

Árváltozás

PerkinElmer Inc Előrejelzés

Célár

By TipRanks

-10.8% elmozdulás lefelé

12 hónapos előrejelzés

Átlag 138 USD  -10.8%

Magas 175 USD

Alacsony 110 USD

14 Wall Street elemző 12 hónapos célárain alapulva a(z)PerkinElmer Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

14 ratings

4

Vétel

10

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat